LAMININ-ALPHA(2) (MEROSIN), BETA-DYSTROGLYCAN, ALPHA-SARCOGLYCAN (ADHALIN), AND DYSTROPHIN EXPRESSION IN CONGENITAL MUSCULAR-DYSTROPHIES - AN IMMUNOHISTOCHEMICAL STUDY

Citation
Hj. Terlaak et al., LAMININ-ALPHA(2) (MEROSIN), BETA-DYSTROGLYCAN, ALPHA-SARCOGLYCAN (ADHALIN), AND DYSTROPHIN EXPRESSION IN CONGENITAL MUSCULAR-DYSTROPHIES - AN IMMUNOHISTOCHEMICAL STUDY, Clinical neurology and neurosurgery, 100(1), 1998, pp. 5-10
Citations number
26
Categorie Soggetti
Clinical Neurology",Surgery
ISSN journal
03038467
Volume
100
Issue
1
Year of publication
1998
Pages
5 - 10
Database
ISI
SICI code
0303-8467(1998)100:1<5:L(BA(>2.0.ZU;2-Q
Abstract
Muscle biopsies of 13 congenital muscular dystrophy (CMD) patients wer e investigated for the expression of laminin-alpha(2) (merosin), beta- dystroglycan, alpha-sarcoglycan (adhalin) and dystrophin. Expression o f these proteins was normal in six out of eight patients with pure-CMD , in three non-Japanese patients clinically resembling Fukuyama-CMD (F -CMD), and in two patients with Walker-Warburg syndrome (WWS). The two 'pure'-CMD patients with white matter hypodensity showed severely dec reased laminin-alpha(2) expression and normal expression of the other proteins. Our findings in the non-Japanese patients, clinically resemb ling F-CMD, are different from those in Japanese cases with F-CMD in t he literature. Consequently, our patients suffer from WWS or from anot her yet undetermined form of CMD. (C) 1998 Elsevier Science B.V. All r ights reserved.